logo
RFK Jr. slashed mRNA vaccine development funding. A Nobel Prize winner just responded

RFK Jr. slashed mRNA vaccine development funding. A Nobel Prize winner just responded

CNN06-08-2025
US Health and Human Services is 'winding down' its mRNA vaccine development and will instead fund other vaccine platforms through the Biomedical Advanced Research and Development Authority, the agency said. 2023 Nobel Laureate in Physiology or Medicine Katalin Karikó reacts.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NASA and SpaceX will launch a resupply mission to the ISS
NASA and SpaceX will launch a resupply mission to the ISS

Yahoo

time3 minutes ago

  • Yahoo

NASA and SpaceX will launch a resupply mission to the ISS

NASA and SpaceX will launch the 33rd commercial resupply mission to the ISS from Cape Canaveral at 2:45 a.m. EDT on Sunday, August 24. The SpaceX Dragon spacecraft is scheduled to dock with the ISS on Monday, August 25, at 7:30 a.m. EDT, carrying more than 5,000 pounds of supplies and scientific experiments. Its objectives include delivering vital materials to the crew and performing experiments that could support future space missions and medical progress on Earth. Onboard science experiments include bone-forming stem cells to study bone loss prevention, materials for 3D-printed medical implants to improve nerve damage treatments, bioprinted liver tissue for blood vessel development in microgravity, and supplies for 3D printing metal cubes. The Dragon spacecraft will perform a reboost to maintain the ISS's altitude, using an independent propellant system to fuel two Draco engines with burns planned throughout Fall 2025. The Dragon spacecraft is expected to stay at the ISS until December, then return to Earth with research and cargo, landing in the Pacific Ocean off the coast of California. Click here to download our free news, weather and smart TV apps. And click here to stream Channel 9 Eyewitness News live. Solve the daily Crossword

Patientory's AI-Enterprise Analytics Dashboard Now Available on Oracle Healthcare Marketplace
Patientory's AI-Enterprise Analytics Dashboard Now Available on Oracle Healthcare Marketplace

Yahoo

time3 minutes ago

  • Yahoo

Patientory's AI-Enterprise Analytics Dashboard Now Available on Oracle Healthcare Marketplace

Patientory's Enterprise Analytics Dashboard is now integrated with Oracle Health technologies to support proactive care, clinical trial recruitment, and strategic decision-making. ATLANTA, Aug. 19, 2025 /PRNewswire/ -- Patientory, Inc., a leading provider of Web3-enabled digital health solutions and an Oracle partner, today announced that its AI-Enterprise Analytics Dashboard is now available on Oracle Healthcare Marketplace and can be integrated with Oracle Health EHR systems. Oracle Healthcare Marketplace is a centralized repository of healthcare applications offered by Oracle and Oracle partners. The Enterprise Analytics Dashboard enables high-level business benefits by providing healthcare organizations with near real-time, AI-powered insights on population health trends, patient adherence, and clinical trial readiness. By running on Oracle Cloud Infrastructure (OCI) and integrating with Oracle Health technologies, the solution empowers providers, payers, and research sponsors to drive value-based care, enhance patient engagement, and improve clinical trial diversity and speed. Oracle Healthcare Marketplace is a one-stop shop for Oracle customers seeking trusted healthcare applications offering unique clinical and business solutions, including ones that extend Oracle Health and Oracle Cloud Applications. "Making our Enterprise Analytics Dashboard available on the Oracle Healthcare Marketplace gives hospitals, research institutions, and health plans the tools to better understand their populations and respond faster," said Chrissa McFarlane, CEO, Patientory, Inc. "Patientory's participation in Oracle Healthcare Marketplace further extends our commitment to the Oracle community and enables customers to easily reap the benefits of our Enterprise Analytics Dashboard. We look forward to leveraging the power of the Oracle Cloud and Oracle Health technologies to help us achieve our business goals." This advanced analytics tool works in conjunction with the Patientory Digital Health Wallet, enabling patient engagement and chronic disease management in alignment with recent White House initiatives focused on digital health equity and chronic care innovation. Patientory will be showcasing the Enterprise Analytics Dashboard at the Oracle Health Summit, September 9–11, 2025, demonstrating how the platform leverages blockchain and AI to create actionable insights for health systems and research institutions. About Patientory, is a pioneer in Web3 digital health solutions, empowering individuals and healthcare organizations with blockchain-based tools to manage health data, reduce costs, and improve outcomes. Our platform bridges the gap between patients, providers, and researchers—enabling real-time analytics, chronic disease management, and decentralized clinical trial more: About Oracle's Partner ProgramOracle's partner program helps Oracle and its partners drive joint customer success and business momentum. The newly enhanced program provides partners with choice and flexibility, offering several program pathways and a robust range of foundational benefits spanning training and enablement, go-to-market collaboration, technical accelerators, and success support. To learn more, visit Trademarks Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing. COMPANY CONTACT INFOsupport@ View original content to download multimedia: SOURCE Patientory Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

FDA warns public not to eat possibly radioactive shrimp sold at Walmart
FDA warns public not to eat possibly radioactive shrimp sold at Walmart

Yahoo

time3 minutes ago

  • Yahoo

FDA warns public not to eat possibly radioactive shrimp sold at Walmart

The Food and Drug Administration is warning the public not to eat, sell or serve certain Great Value raw frozen shrimp sold at Walmart due to possible contamination with Cesium-137, a radioactive isotope. U.S. Customs and Border Protection alerted the FDA about possible Cesium-137, or Cs-137, detected in shipping containers at four U.S. ports, the FDA said Tuesday in a press release. Testing on frozen shrimp from the distributor, Indonesia's BMS Foods, also tested positive, the FDA said. MORE: Nationwide bologna lunch meat recall: What to know about the products However, no shrimp that has tested positive for Cesium-137 has entered the U.S. food supply, according to the FDA. The FDA is still recommending a recall on all products from BMS Foods that were shipped after the company's shipping containers tested positive for Cesium-137, even though the products themselves have not tested positive. The following Great Value brand frozen shrimp products should not be eaten, sold or served: Great Value brand frozen raw shrimp, lot code: 8005540-1, Best by Date: 3/15/2027 Great Value brand frozen raw shrimp, lot code: 8005538-1, Best by Date: 3/15/2027 Great Value brand frozen raw shrimp, lot code: 8005539-1, Best by Date: 3/15/2027 All products from the company are now banned from coming into the U.S. "until the firm has resolved the conditions that gave rise to the appearance of the violation," the FDA said. This is a developing story. Please check back for updates.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store